# Meyer Ventures

> Meyer Ventures is a VC fund in New York backing Medical and Health Care. See 15 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 15
- Last investment: Mar 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/ocean-road-inc
- Website: http://meyerandco.com

Meyer Ventures is a merchant bank focused on strategic growth investments & the management of a "FAMILY OFFICE" portfolio

## Contacts

5 contacts available for Meyer Ventures. Shizune tracks 1 team members at Meyer Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/meyer-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 5 | 33% |
| Health Care | 5 | 33% |
| Software | 3 | 20% |
| Biotechnology | 3 | 20% |
| SaaS | 2 | 13% |

39 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 33% |
| Series A | 5 | 33% |
| Series B | 2 | 13% |
| Series E | 1 | 7% |
| Secondary Market | 1 | 7% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Anthony Meyer | Chairman and Chief Executive Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Volastra Therapeutics | Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability | $60M | Series A | Mar 07, 2023 |  |
| 98point6 | 98point6 is a digital primary care service that delivers personalized consultation, diagnosis, and treatment to patients. The company combines deep technology with the expertise of board-certified physicians to provide text-based primary care anytime, anywhere. The company meets consumers where they are by offering private, text-based diagnosis andtreatment via a mobile app. The company was founded in 2015 and is headquartered in Seattle, Washington. | $118M | Series E | Oct 15, 2020 |  |
| Noteworth | Noteworth is connecting healthcare organizations to patient-generated health data and provides software and services that allow clinicians and healthcare organizations to have an unprecedented level of health data clarity for patients outside the clinic.The startup company works with primary care doctors, pediatricians, and specialists to improvepatient engagement on an ongoing basis, whether it be through collecting information on vitals, providing education on diagnosis, and avenues to talk to a doctor via telemedicine or chat. Its HIPAA-compliant, interoperable solution integrates with 400+ FDA-approved clinical devices and delivers patient-generated data directly into an existing electronic medical record (EMR) in actionable, clinically-relevant Noteworth Reports. They position their partners to target costly readmissions, reduce utilization, boost patient satisfaction, and increase the overall quality of care.The Hoboken, New Jersey-based company was founded by Bryan Bonnet, Justin Williams, and Nishant Panchal in 2015. | $5M | Seed | Jul 14, 2020 |  |
| ReferWell | ReferWell connects providers into Virtually Integrated Networks that optimize transitions of care. We help you drive the patient journey through the last mile with complete visibility into all interactions—so providers and payers can close the loop efficiently.With our system, you’ll direct patients toward the highest-quality providers, increasepatient compliance, reduce leakage and close more care gaps. Clients raise revenue by increasing keepage, improving STAR ratings and getting more members’ HCC coding updated. Our comprehensive suite of services connects to all your EMRs for streamlined referrals, point-of-care appointment scheduling and care team support, including provider directory management, eConsult and telehealth capabilities. |  | Venture - Series Unknown | Mar 25, 2020 |  |
| Next Big Idea Club | Next Big Idea Club is a subscription book club. Their goal is to make sure that everyone has access to these transformative ideas, and to nurture a community to discuss and build upon those ideas—both with each other and directly with the authors themselves. |  | Seed | Jan 22, 2020 |  |
| AIStorm | AIStorm is an AI startup that develops chipsets that can process data directly from devices. AIS technology is analog and mixed-signal technology. The sensor itself can deal with events, make decisions, and can perform complex analysis. The company was founded in 2011 and is headquartered in San Jose, California. | $13.2M | Series A | Feb 11, 2019 |  |
| Slack | Slack is a cloud-based communication and collaboration platform for teams. It allows users to exchange messages, share files, and integrate with various business tools and services. Slack is commonly used across various industries, from tech startups to large enterprises. |  | Secondary Market | Jan 28, 2019 |  |
| DailyPay | DailyPay offers a platform that allows employees to access their earned wages before their scheduled payday. The service integrates with employer payroll systems and provides tools for financial wellness. DailyPay aims to improve employee retention and engagement through flexible pay access. |  | Seed | Oct 31, 2015 |  |
| 1DocWay | 1DocWay is an online doctor's office. Rural, elderly, disabled and busy patients can schedule appointments online and see their doctor through our secure videochat platform. As a result, physicians increase scheduling flexibility and revenue opportunities by expanding their patient base, increasing reimbursement rates and replacing phone calls(not reimbursed) | $1.7M | Seed | Jul 21, 2015 |  |
| PierianDx | PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by healthsystems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report. | $3.9M | Series A | Jun 16, 2015 |  |

10 of 15 investments shown.

## Co-investors
- [Frontier Venture Capital](https://shizune.co/investors/profile/dfj-frontier) — VC Fund, 2 deals together
- [Health Catalyst Capital](https://shizune.co/investors/profile/health-catalyst-capital) — VC Fund, 2 deals together
- Silicon Alley Venture Partners — VC Fund, 2 deals together
- [Stonehenge Capital](https://shizune.co/investors/profile/stonehenge-capital) — VC Fund, 2 deals together
- ZL LLC — VC Fund, 2 deals together
- [10x Group](https://shizune.co/investors/profile/10xgroup) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Meyer Ventures invest in?

Meyer Ventures invests primarily in Medical, Health Care and Software startups, most often at Seed and Series A stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Meyer Ventures?

Public channels for Meyer Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Meyer Ventures?

The team at Meyer Ventures includes Anthony Meyer (Chairman and Chief Executive Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co